|Quell nerve stimulation device--Courtesy of NeuroMetrix|
A wearable pain relief device is set to hit store shelves, thanks to NeuroMetrix's ($NURO) distribution agreement with Advantage Consumer Healthcare.
The Quell nerve stimulation device is worn around the upper calf. Delivered via an electrode at the click of button, the stimulation causes the brain to release endogenous opioids into the spine, thereby blocking pain signals, NeuroMetrix says on its website.
There is a downloadable iPhone app for tracking therapy and controlling features. In addition, NeuroMetrix says the device contains an accelerometer that adjusts the device when the user is sleeping.
Quell is for people with nerve pain, sciatica, osteoarthritis and fibromyalgia, among other pain conditions, according to a release. It's currently available through selected healthcare professionals and the Internet.
"We are excited to have Advantage lead our retail launch. Retail expansion is a key component of our strategy, combined with an ongoing relationship with healthcare professionals," said NeuroMetrix senior vice president Frank McGillin. "Advantage demonstrated a unique understanding of the marketplace and how to create new categories within the major U.S. retailers. Their portfolio is primarily high growth, cutting edge brands such as Quell."
Quell received the FDA's 510(k) clearance as an over-the-counter device in July 2014. NeuroMetrix also sells the wearable Sensus pain management device.
The development marks step forward for wearable devices. In addition to fighting pain, they can also be used to collect data. The journal Neurology Now just highlighted some wristbands, smartwatches and other gizmos for the real-time monitoring of neurological symptoms, like seizures in the case of epilepsy.
And Axiobionics just announced the rollout of a new line of wearable rehabilitation devices for patients with leg paralysis, adding to its suite of muscle therapy products while offering an alternative to traditional orthotics.
- read the release